{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T03:50:59Z","timestamp":1763178659866},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T00:00:00Z","timestamp":1311724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00115-011-3258-y","type":"journal-article","created":{"date-parts":[[2011,7,25]],"date-time":"2011-07-25T17:12:24Z","timestamp":1311613944000},"page":"994-1001","source":"Crossref","is-referenced-by-count":15,"title":["Das pr\u00e4symptomatische Stadium neurodegenerativer Erkrankungen"],"prefix":"10.1007","volume":"82","author":[{"given":"C.","family":"Klein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hagenah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Landwehrmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"M\u00fcnte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Klockgether","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,27]]},"reference":[{"key":"3258_CR1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00702-006-0449-y","volume":"113","author":"Halliday","year":"2006","unstructured":"Halliday GM, Fedorow H, Rickert CH et al (2006) Evidence for specific phases in the development of human neuromelanin. J Neural Transm 113(6):721\u2013728","journal-title":"J Neural Transm"},{"key":"3258_CR2","doi-asserted-by":"crossref","unstructured":"Klein C, Krainc D, Schlossmacher MG, Lang AE (2011) Translational research in neurology and neuroscience 2011: movement disorders. Arch Neurol (in press)","DOI":"10.1001\/archneurol.2011.11"},{"key":"3258_CR3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.ne.19.030196.000455","volume":"19","author":"Paulson","year":"1996","unstructured":"Paulson HL, Fischbeck KH (1996) Trinucleotide repeats in neurogenetic disorders. Annu Rev Neurosci 19:79\u2013107","journal-title":"Annu Rev Neurosci"},{"key":"3258_CR4","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s00115-010-3024-6","volume":"81","author":"Bruggemann","year":"2010","unstructured":"Bruggemann N, Vegt J, Klein C, Siebner HR (2010) Imaging of genetic aspects of Parkinson\u2019s disease. Nervenarzt 81(10):1196\u20131203","journal-title":"Nervenarzt"},{"key":"3258_CR5","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/01.wnl.0000338699.56379.11","volume":"72","author":"Nuenen","year":"2009","unstructured":"Nuenen BF van, Weiss MM, Bloem BR et al (2009) Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype. Neurology 72(12):1041\u20131047","journal-title":"Neurology"},{"key":"3258_CR6","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/mds.23574","volume":"26","author":"Vaccarino","year":"2011","unstructured":"Vaccarino AL, Anderson K, Borowsky B et al (2011) An item response analysis of the motor and behavioral subscales of the unified Huntington\u2019s disease rating scale in Huntington disease gene expansion carriers. Mov Disord 26(5):877\u2013884","journal-title":"Mov Disord"},{"key":"3258_CR7","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","volume":"79","author":"Paulsen","year":"2008","unstructured":"Paulsen JS, Langbehn DR, Stout JC et al (2008) Detection of Huntington\u2019s disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry 79(8):874\u2013880","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3258_CR8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"Tabrizi","year":"2009","unstructured":"Tabrizi SJ, Langbehn DR, Leavitt BR et al (2009) Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 8(9):791\u2013801","journal-title":"Lancet Neurol"},{"key":"3258_CR9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","volume":"10","author":"Tabrizi","year":"2011","unstructured":"Tabrizi SJ, Scahill RI, Durr A et al (2011) Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 10(1):31\u201342","journal-title":"Lancet Neurol"},{"key":"3258_CR10","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/WNL.0b013e3181fc27e4","volume":"75","author":"Sturrock","year":"2010","unstructured":"Sturrock A, Laule C, Decolongon J et al (2010) Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease. Neurology 75(19):1702\u20131710","journal-title":"Neurology"},{"key":"3258_CR11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(10)70183-6","volume":"9","author":"Durr","year":"2010","unstructured":"Durr A (2010) Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol 9(9):885\u2013894","journal-title":"Lancet Neurol"},{"key":"3258_CR12","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1212\/01.wnl.0000325057.33666.72","volume":"71","author":"Schmitz-Hubsch","year":"2008","unstructured":"Schmitz-Hubsch T, Coudert M, Bauer P et al (2008) Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology 71(13):982\u2013989","journal-title":"Neurology"},{"key":"3258_CR13","doi-asserted-by":"crossref","unstructured":"Jacobi H, Bauer P, Giunti P et al (2011) The naturalhistory of spinocerebellar ataxia type1, 2, 3, and 6: a 2-year follow-up study. Neurology (in press)","DOI":"10.1212\/WNL.0b013e31822e7ca0"},{"key":"3258_CR14","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/mds.22288","volume":"23","author":"Globas","year":"2008","unstructured":"Globas C, Montcel ST du, Baliko L et al (2008) Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6. Mov Disord 23(15):2232\u20132238","journal-title":"Mov Disord"},{"key":"3258_CR15","doi-asserted-by":"crossref","first-page":"e5398","DOI":"10.1371\/journal.pone.0005398","volume":"4","author":"Velazquez-Perez","year":"2009","unstructured":"Velazquez-Perez L, Diaz R, Perez-Gonzalez R et al (2009) Motor decline in clinically presymptomatic spinocerebellar ataxia type 2 gene carriers. PLoS One 4(4):e5398","journal-title":"PLoS One"},{"key":"3258_CR16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/mds.23409","volume":"26","author":"Rodriguez-Labrada","year":"2011","unstructured":"Rodriguez-Labrada R, Velazquez-Perez L, Ochoa NC et al (2011) Subtle rapid eye movement sleep abnormalities in presymptomatic spinocerebellar ataxia type 2 gene carriers. Mov Disord 26(2):347\u2013350","journal-title":"Mov Disord"},{"key":"3258_CR17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archneur.65.4.530","volume":"65","author":"Christova","year":"2008","unstructured":"Christova P, Anderson JH, Gomez CM (2008) Impaired eye movements in presymptomatic spinocerebellar ataxia type 6. Arch Neurol 65(4):530\u2013536","journal-title":"Arch Neurol"},{"key":"3258_CR18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(10)62345-8","volume":"377","author":"Nalls","year":"2011","unstructured":"Nalls MA, Plagnol V, Hernandez DG et al (2011) Imputation of sequence variants for identification of genetic risks for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet 377(9766):641\u2013649","journal-title":"Lancet"},{"key":"3258_CR19","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1212\/WNL.0b013e3181e0f79c","volume":"74","author":"Eggers","year":"2010","unstructured":"Eggers C, Schmidt A, Hagenah J et al (2010) Progression of subtle motor signs in PINK1 mutation carriers with mild dopaminergic deficit. Neurology 74(22):1798\u20131805","journal-title":"Neurology"},{"key":"3258_CR20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/mds.23602","volume":"26","author":"Baba","year":"2011","unstructured":"Baba T, Takeda A, Kikuchi A et al (2011) Association of olfactory dysfunction and brain. Metabolism in Parkinson\u2019s disease. Mov Disord 26(4):621\u2013628","journal-title":"Mov Disord"},{"key":"3258_CR21","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/mds.21989","volume":"23","author":"Fujishiro","year":"2008","unstructured":"Fujishiro H, Frigerio R, Burnett M et al (2008) Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson\u2019s disease. Mov Disord 23(8):1085\u20131092","journal-title":"Mov Disord"},{"key":"3258_CR22","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1136\/jnnp.2009.174748","volume":"81","author":"Postuma","year":"2011","unstructured":"Postuma RB, Gagnon JF, Montplaisir J (2011) Clinical prediction of Parkinson\u2019s disease: planning for the age of neuroprotection. J Neurol Neurosurg Psychiatry 81(9):1008\u20131013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3258_CR23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00702-010-0565-6","volume":"118","author":"Berg","year":"2011","unstructured":"Berg D (2011) Substantia nigra hyperechogenicity is a risk marker of Parkinson\u2019s disease: yes. J Neural Transm 118(4):613\u2013619","journal-title":"J Neural Transm"},{"key":"3258_CR24","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/jnnp.2007.142174","volume":"79","author":"Hagenah","year":"2008","unstructured":"Hagenah JM, Becker B, Bruggemann N et al (2008) Transcranial sonography findings in a large family with homozygous and heterozygous PINK1 mutations. J Neurol Neurosurg Psychiatry 79(9):1071\u20131074","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3258_CR25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/JAD-2010-1244","volume":"19","author":"Della","year":"2010","unstructured":"Della Sala S, Cocchini G, Logie RH et al (2010) Dual task during encoding, maintenance, and retrieval in Alzheimer\u2019s disease. J Alzheimers Dis 19(2):503\u2013515","journal-title":"J Alzheimers Dis"},{"key":"3258_CR26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/PL00014168","volume":"249","author":"Braak","year":"1999","unstructured":"Braak E, Griffing K, Arai K et al (1999) Neuropathology of Alzheimer\u2019s disease: what is new since A. Alzheimer? Eur Arch Psychiatry Clin Neurosci 249(Suppl 3):14\u201322","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3258_CR27","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.neurobiolaging.2005.10.002","volume":"27","author":"Wang","year":"2006","unstructured":"Wang PN, Lirng JF, Lin KN et al (2006) Prediction of Alzheimer\u2019s disease in mild cognitive impairment: a prospective study in Taiwan. Neurobiol Aging 27(12):1797\u20131806","journal-title":"Neurobiol Aging"},{"key":"3258_CR28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neurobiolaging.2006.09.013","volume":"29","author":"Lerch","year":"2008","unstructured":"Lerch JP, Pruessner J, Zijdenbos AP et al (2008) Automated cortical thickness measurements from MRI can accurately separate Alzheimer\u2019s patients from normal elderly controls. Neurobiol Aging 29(1):23\u201330","journal-title":"Neurobiol Aging"},{"key":"3258_CR29","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/brain\/awq075","volume":"133","author":"Zhou","year":"2010","unstructured":"Zhou J, Greicius MD, Gennatas ED et al (2010) Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer\u2019s disease. Brain 133(5):1352\u20131367","journal-title":"Brain"},{"key":"3258_CR30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","volume":"2","author":"Blennow","year":"2003","unstructured":"Blennow K, Hampel H (2003) CSF markers for incipient Alzheimer\u2019s disease. Lancet Neurol 2(10):605\u2013613","journal-title":"Lancet Neurol"},{"key":"3258_CR31","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","volume":"5","author":"Hansson","year":"2006","unstructured":"Hansson O, Zetterberg H, Buchhave P et al (2006) Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 5(3):228\u2013234","journal-title":"Lancet Neurol"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-011-3258-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-011-3258-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-011-3258-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T18:40:33Z","timestamp":1638124833000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-011-3258-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,27]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["3258"],"URL":"https:\/\/doi.org\/10.1007\/s00115-011-3258-y","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,27]]}}}